Related Experiment Video
Updated: Apr 22, 2026

Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins
Published on: June 14, 2016
Caenorhabditis elegans bacterial pathogen resistant bus-4 mutants produce altered mucins
Lisa M Parsons1, Rahman M Mizanur1, Ewa Jankowska1
1Food and Drug Administration, Center for Biologics Evaluation and Research, Bethesda, Maryland, United States of America.
Abstract:
Caenorabditis elegans bus-4 glycosyltransferase mutants are resistant to infection by Microbacterium nematophilum, Yersinia pestis and Yersinia pseudotuberculosis and have altered susceptibility to two Leucobacter species Verde1 and Verde2. Our objective in this study was to define the glycosylation changes leading to this phenotype to better understand how these changes lead to pathogen resistance. We performed MALDI-TOF MS, tandem MS and GC/MS experiments to reveal fine structural detail for the bus-4 N- and O-glycan pools. We observed dramatic changes in O-glycans and moderate ones in N-glycan pools compared to the parent strain. Ce core-I glycans, the nematode's mucin glycan equivalent, were doubled in abundance, halved in charge and bore shifts in terminal substitutions. The fucosyl O-glycans, Ce core-II and neutral fucosyl forms, were also increased in abundance as were fucosyl N-glycans. Quantitative expression analysis revealed that two mucins, let-653 and osm-8, were upregulated nearly 40 fold and also revealed was a dramatic increase in GDP-Man 4,6 dehydratease expression. We performed detailed lectin binding studies that showed changes in glycoconjugates in the surface coat, cuticle surface and intestine. The combined changes in cell surface glycoconjugate distribution, increased abundance and altered properties of mucin provide an environment where likely the above pathogens are not exposed to normal glycoconjugate dependent cues leading to barriers to these bacterial infections.
Insights
Caenorabditis elegans bus-4 mutants show altered glycosylation, conferring resistance to bacterial pathogens. These changes in N- and O-glycans create a barrier, preventing pathogen attachment and infection.
Area of Science:
- Glycobiology
- Nematology
- Microbiology
Background:
- Caenorhabditis elegans bus-4 glycosyltransferase mutants exhibit resistance to several bacterial pathogens.
- Understanding the underlying glycosylation changes is crucial for elucidating pathogen resistance mechanisms.
Purpose of the Study:
- To define the specific glycosylation alterations in bus-4 mutants.
- To correlate these changes with observed pathogen resistance phenotypes.
Main Methods:
- Mass spectrometry (MALDI-TOF MS, tandem MS, GC/MS) for glycan structural analysis.
- Quantitative expression analysis of mucin genes (let-653, osm-8) and GDP-Man 4,6 dehydratase.
- Lectin binding studies to assess cell surface glycoconjugate distribution.
Main Results:
- Significant alterations in both O-glycan and N-glycan pools were observed in bus-4 mutants.
- Increased abundance of Ce core-I and fucosyl O- and N-glycans.
- Upregulation of mucins and GDP-Man 4,6 dehydratase, with altered surface glycoconjugate distribution.
Conclusions:
- Altered mucin abundance, charge, and terminal substitutions contribute to pathogen resistance.
- Changes in cell surface and intestinal glycoconjugates likely impede bacterial recognition and infection.
- Glycosylation modifications in bus-4 mutants provide a defense mechanism against specific bacterial pathogens.

